• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

功能化水凝胶在心肌梗死治疗和药物输送策略中的进展。

Advances in Functionalized Hydrogels in the Treatment of Myocardial Infarction and Drug-Delivery Strategies.

机构信息

Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, China.

Shanxi Academy of Advanced Research and Innovation, Taiyuan 030032, China.

出版信息

ACS Appl Mater Interfaces. 2024 Sep 18;16(37):48880-48894. doi: 10.1021/acsami.4c09623. Epub 2024 Sep 3.

DOI:10.1021/acsami.4c09623
PMID:39227344
Abstract

Myocardial infarction (MI) is a serious cardiovascular disease with high morbidity and mortality rates, posing a significant threat to patient's health and quality of life. Following a MI, the damaged myocardial tissue is typically not fully repaired, leading to permanent impairment of myocardial function. While traditional treatments can alleviate symptoms and reduce pain, their ability to repair damaged heart muscle tissue is limited. Functionalized hydrogels, a broad category of materials with diverse functionalities, can enhance the properties of hydrogels to cater to the needs of tissue engineering, drug delivery, medical dressings, and other applications. Recently, functionalized hydrogels have emerged as a promising new therapeutic approach for the treatment of MI. Functionalized hydrogels possess outstanding biocompatibility, customizable mechanical properties, and drug-release capabilities. These properties enable them to offer scaffold support, drug release, and tissue regeneration promotion, making them a promising approach for treating MI. This paper aims to evaluate the advancements and delivery methods of functionalized hydrogels for treating MI, while also discussing their potential and the challenges they may pose for future clinical use.

摘要

心肌梗死(MI)是一种严重的心血管疾病,发病率和死亡率都很高,对患者的健康和生活质量构成重大威胁。MI 发生后,受损的心肌组织通常无法完全修复,导致心肌功能永久受损。虽然传统治疗可以缓解症状和减轻疼痛,但它们修复受损心肌组织的能力有限。功能化水凝胶是一类具有多种功能的广泛材料,可以增强水凝胶的性能,以满足组织工程、药物输送、医用敷料等应用的需求。最近,功能化水凝胶作为治疗 MI 的一种有前途的新治疗方法出现了。功能化水凝胶具有出色的生物相容性、可定制的机械性能和药物释放能力。这些特性使它们能够提供支架支撑、药物释放和组织再生促进作用,因此是治疗 MI 的一种很有前途的方法。本文旨在评估功能化水凝胶在治疗 MI 方面的最新进展和递送方法,同时讨论其潜在应用和未来临床应用可能面临的挑战。

相似文献

1
Advances in Functionalized Hydrogels in the Treatment of Myocardial Infarction and Drug-Delivery Strategies.功能化水凝胶在心肌梗死治疗和药物输送策略中的进展。
ACS Appl Mater Interfaces. 2024 Sep 18;16(37):48880-48894. doi: 10.1021/acsami.4c09623. Epub 2024 Sep 3.
2
Progresses and perspectives on natural polysaccharide based hydrogels for repair of infarcted myocardium.天然多糖水凝胶修复梗死心肌的研究进展与展望。
Int J Biol Macromol. 2024 Jun;269(Pt 2):132213. doi: 10.1016/j.ijbiomac.2024.132213. Epub 2024 May 8.
3
Hydrogel formulations for orthotopic treatment of myocardial infarction.水凝胶制剂用于心肌梗死的原位治疗。
Expert Opin Drug Deliv. 2024 Oct;21(10):1463-1478. doi: 10.1080/17425247.2024.2409906. Epub 2024 Oct 3.
4
Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction.可注射水凝胶治疗及其传递策略治疗心肌梗死。
Expert Opin Drug Deliv. 2013 Jan;10(1):59-72. doi: 10.1517/17425247.2013.739156. Epub 2012 Nov 9.
5
Hydrogels as a Potential Biomaterial for Multimodal Therapeutic Applications.水凝胶作为一种潜在的多模式治疗应用的生物材料。
Mol Pharm. 2024 Oct 7;21(10):4827-4848. doi: 10.1021/acs.molpharmaceut.4c00595. Epub 2024 Sep 18.
6
Biohybrid cardiac ECM-based hydrogels improve long term cardiac function post myocardial infarction.基于生物杂交心脏细胞外基质的水凝胶可改善心肌梗死后的长期心脏功能。
Acta Biomater. 2017 Mar 1;50:220-233. doi: 10.1016/j.actbio.2016.12.015. Epub 2016 Dec 9.
7
Latest progress of self-healing hydrogels in cardiac tissue engineering.心脏组织工程中自修复水凝胶的最新进展。
Biomed Microdevices. 2024 Aug 16;26(3):36. doi: 10.1007/s10544-024-00716-z.
8
Progress in cardiac tissue engineering and regeneration: Implications of gelatin-based hybrid scaffolds.心脏组织工程与再生的进展:基于明胶的杂化支架的影响。
Int J Biol Macromol. 2024 Mar;261(Pt 2):129924. doi: 10.1016/j.ijbiomac.2024.129924. Epub 2024 Feb 2.
9
An injectable chitosan/dextran/β -glycerophosphate hydrogel as cell delivery carrier for therapy of myocardial infarction.一种可注射的壳聚糖/葡聚糖/β-甘油磷酸盐水凝胶作为细胞输送载体,用于治疗心肌梗死。
Carbohydr Polym. 2020 Feb 1;229:115516. doi: 10.1016/j.carbpol.2019.115516. Epub 2019 Oct 31.
10
Unveiling the versatility of gelatin methacryloyl hydrogels: a comprehensive journey into biomedical applications.揭示甲基丙烯酰化明胶水凝胶的多功能性:生物医学应用的综合之旅。
Biomed Mater. 2024 Jun 3;19(4). doi: 10.1088/1748-605X/ad4df7.

引用本文的文献

1
Multifunctional applications of hydrogel materials in myocardial infarction treatment: from tissue repair to microenvironment regulation.水凝胶材料在心肌梗死治疗中的多功能应用:从组织修复到微环境调节
RSC Adv. 2025 Sep 2;15(38):31564-31585. doi: 10.1039/d5ra05286f. eCollection 2025 Aug 29.
2
Integrating Deep Learning and Real-Time Imaging to Visualize In Situ Self-Assembly of Self-Healing Interpenetrating Polymer Networks Formed by Protein and Polysaccharide Fibers.整合深度学习与实时成像以可视化由蛋白质和多糖纤维形成的自愈合互穿聚合物网络的原位自组装。
ACS Appl Mater Interfaces. 2025 Aug 20;17(33):46771-46785. doi: 10.1021/acsami.5c11459. Epub 2025 Aug 5.
3
Scalable Biofabrication of Functional 3D Scaffolds via Synergy of Autopilot Single-Jet Electrospun 3D PCL Fiber Scaffolds and Cell-Laden Hydrogels.
通过自动驾驶单喷电纺3D聚己内酯纤维支架与载细胞水凝胶的协同作用实现功能性3D支架的可扩展生物制造
ACS Appl Mater Interfaces. 2025 Aug 27;17(34):47878-47893. doi: 10.1021/acsami.5c07425. Epub 2025 Jul 22.
4
[Advances in hydrogel drug delivery systems for myocardial infarction treatment].[用于心肌梗死治疗的水凝胶药物递送系统的进展]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025 Jul 17;54(4):455-468. doi: 10.3724/zdxbyxb-2025-0087.
5
Recent progress in ROS-responsive biomaterials for the diagnosis and treatment of cardiovascular diseases.用于心血管疾病诊断与治疗的活性氧响应性生物材料的最新进展
Theranostics. 2025 Apr 11;15(11):5172-5219. doi: 10.7150/thno.106991. eCollection 2025.
6
Inflammatory Cell-Targeted Delivery Systems for Myocardial Infarction Treatment.用于心肌梗死治疗的炎症细胞靶向递送系统
Bioengineering (Basel). 2025 Feb 19;12(2):205. doi: 10.3390/bioengineering12020205.